POGO

  • Staff List
  • Contact Us

Main menu

Skip to primary content
Skip to secondary content
  • About Us
    • Our Mission and Vision
    • Childhood Cancer Care Plan
    • POGO Land Acknowledgement
    • Diversity, Equity, Inclusion
    • Our Board
    • Our Partners
    • Our Donors
    • Privacy
    • Accessibility
    • Reports
    • Newsroom
    • Job Opportunities
    • Staff List
  • Programs & Support
    • Patient Care Programs
    • Financial Assistance
    • Survivor Care
    • Cancer Resources
    • Inspiring Stories
    • Clinical and Program Advisory Committees
  • Education
    • POGO Virtual Education
    • Indigenous Resource Guide
    • All Education Events & Conferences
  • Healthcare Practice
    • COVID-19 Updates
    • Pediatric Oncology Nursing
    • Clinical Practice Guidelines
    • POGO Satellite Manual
  • Research & Data
    • 2020 POGO Surveillance Report
    • POGO Research Unit
    • POGONIS – Childhood Cancer Database
    • Data Reports
    • Data Requests
  • Get Involved
    • Pajamas and Pancakes
    • Birthday Parties for POGO
    • Events
    • Volunteer
  • Ways to Give
    • Donate
    • Gifts of Stock and Securities
    • Become a Corporate Partner
    • Gifts in Honour/Memory
    • Legacy Gifts
    • Shop Online/Earn Cash Back

Blog

POGO > Blog > 2013 Pre-Symposium Nursing Seminar
[sharethis]

Tag: 2013 Pre-Symposium Nursing Seminar


Post navigation

← Older posts

POGO Celebrates Pediatric Oncology Nursing Excellence with Bruna DiMonte

Posted on April 3, 2018 by admin

Bruna DiMonte, POGO Senior Database Administrator and Privacy Officer, and nurse at The Hospital for Sick Children

“Excellence in oncology nursing is about demonstrating a high level of compassion, empathy and pediatric oncology specialty expertise in caring for kids with cancer and their families. Nurses incorporate evidence-based literature and research in our clinical practice, and we are excellent resources to allied health teams and the field of pediatric oncology. We advocate for resources to meet the challenging needs of kids with cancer, families, pediatric oncology nursing and the childhood cancer care system.”

Data Drives Practice
These days, my work at SickKids overlaps with my data management role at POGO. In both organizations, I lead teams responsible for capturing data in our POGONIS database. This data—clinical information that includes specifics about children’s diagnosis, treatment, complications and long-term outcomes—is used by POGO and our system partners for cancer surveillance, research, decision-making, system and program planning and evaluation, and policy advice.

Her Passion for Her Patients and Work as a Pediatric Oncology Nurse
My early career was devoted to working on the frontlines and in doing so, I always strived to provide compassionate care to kids with cancer. While it’s hard to choose, I would say that one of the most rewarding things was finding time in my day to play with a child and distract them from the complex cancer treatment I still had to provide. Every day brought a new set of challenges and however a child’s story played out, my only hope was that I had made a positive difference in their life and their family’s.

POGO Values Pediatric Oncology Nurses
I have had the pleasure of helping POGO support pediatric oncology nurses in making valuable contributions to the pediatric oncology community. I am the staff representative on the POGO Nursing Committee and have worked with Committee members on such special projects as POGO guidance documents about telephone practices (telepractice) and the safe handling of antineoplastic agents. The Committee has also had the opportunity to contribute to publications, abstracts, presentations at conferences of health organizations like the Association of Pediatric Hematology/Oncology Nurses (APHON), The International Society of Pediatric Oncology (SIOP), and POGO education events like AfterCare Education Day, the Annual Multidisciplinary Symposium on Childhood Cancer and Nursing Pre-Symposia education events. Through POGO, pediatric oncology nurses also have the opportunity to advocate on a policy level, and in the past actively supported POGO’s recommendation of the nurse coordinator position and acquisition of the  Interlink Nursing program. POGO also proactively seeks preceptorships with nursing student placements at the POGO office and with the POGO Interlink Nurses at their hospitals.

Other Career Achievements of which Bruna is Most Proud
This is another difficult question as I have had many wonderful opportunities to support novice pediatric oncology nurses, as well as data managers and researchers. I hope I have helped empower others to provide excellent clinical care. And, in collaborating with researchers using POGONIS data for epidemiological research and data analysis, I hope I have adequately supported their policy planning and program development goals for pediatric oncology, and inspired them to collect accurate provincial population data for these needs.


Bruna DiMonte, RN, BScN, has been a pediatric nurse for 36 years and has spent 28 of those working double duty at The Hospital for Sick Children (SickKids) in Toronto and with POGO as the Senior Database Administrator and Privacy Officer

Posted in Misc | Tagged 2013 Pre-Symposium Nursing Seminar, canadian oncology nursing day, nursing, pediatric oncology nursing, POGONIS database

2013 Pre-Symposium Seminar

Posted on March 4, 2014 by admin


The 2013 Pre-Symposium seminar focused on Innovation in Pediatric Oncology Nursing, and aimed to provide nurses with the latest information on innovations that are revolutionizing pediatric cancer in a number of areas, including: MIBG therapy, innovative outpatient chemotherapy, blood and marrow transplantation, and many others. Over 90 nurses and other health providers attended the day.

VIEW THE PROGRAM

NOTE: The content of each presentation below captures the unedited information and opinions presented by the speakers. Please note that the information contained in the presentations was current at the time it was presented – there may be further information in subsequent literature. Listed speaker credentials were current at the time of presentation.

Oncology Nursing at the Heart of Health Care: Driving Change and Innovation
Lynn Kachuik, RN, BA, MS, CON(C), CHPCN(C)

131I- MIBG Therapy: Living in a Lead Lined World
Denise Mills, RN(EC) MN NP
Sharleen Sawicki, RN, BScN, CPHON

Spotlight on Solid Tumours
Hanna Tseitlin, RN (EC), MN, PNP

Demystifying Blood and Marrow Transplantation
Christine Armstrong, RN(EC), MScN
Sarah Courtney, RN (EC), MN, NP Pediatrics
Mary Jo De Courcy, RN, MScN, NP Pediatrics

Providing Research Results to Participants
Conrad Fernandez, MD, FRCPC

PTLD: A Primer
Angela Punnett, MD, FRCPC

Risk Stratification in Neuroblastoma
Denise Mills, RN(EC) MN NP

New & Now – Four Studies that are Changing the Landscape of Care
Continuous Quality Improvement in Pediatric Oncology – Utilizing Lean Methodology to Standardize Chemotherapy Administration Practices
Erin O’Shaughnessy, RN, MScN, CPHON
Martha Pinheiro-Maltez, RN, MScN

Rapid Hydration: Small Change with Big Gains
Julie Watson, MSN, RN(EC)

Feasibility, Acceptability and Effectiveness of a Sleep Hygiene and Relaxation Intervention to Improve Sleep and Fatigue for Children on Maintenance Chemotherapy for ALL
Sue Zupanec, MN, NP Pediatrics

Understanding Body Image, Sexuality, Dating, Friendships and Fertility in Adolescents with Cancer from an Adolescent and Parent Perspective
Lindsay Jibb, RN, MSc, PhD student

The Power of the Backpack
Eleanor Hendershot RN(EC), MN, BScN
Sandra Ross, BA, RN

Posted in 2013 Pre-Symposium Nursing Seminar - Innovation in Pediatric Oncology Nursing, Education for Health Professionals | Tagged 2013 Pre-Symposium Nursing Seminar, nursing

Oncology Nursing at the Heart of Health Care: Driving Change and Innovation

Posted on March 4, 2014 by admin


Presentation Description:
Nurses have always been at the centre of the health care system, having the most direct interface with patients and families. Oncology nurses are well positioned to examine care from a longitudinal perspective since our patients and families require frequent visits for a prolonged period as part of their treatment. Patient/family centred care is a core competency of oncology nursing as is advocacy. Oncology nurses, nested within the interprofessional team, can identify barriers to excellent care, advocate for required changes and work to implement innovations in care to improve outcomes. This presentation explored the role of oncology nurses in championing quality, holistic care for patients and families using exemplars from the literature, as well as cases from current clinical practice.

Speaker:
Lynn Kachuik, RN, BA, MS, CON(C), CHPCN(C)
Advanced Practice Nurse, Palliative Care
Ottawa Hospital, Ottawa

Posted in 2013 Pre-Symposium Nursing Seminar - Innovation in Pediatric Oncology Nursing, Education for Health Professionals | Tagged 2013 Pre-Symposium Nursing Seminar, nursing, patient advocacy, patient care

131I- MIBG Therapy: Living in a Lead-Lined World

Posted on March 4, 2014 by admin


Presentation Description:
Despite advances in the treatment of high-risk neuroblastoma, cure rates remain <50% with neuroblastoma accounting for 15% of all pediatric oncology deaths (Maris, 2007, 2010). In Canada, there are 60-70 children newly diagnosed with neuroblastoma each year, with 50% of these cases being stage IV disease (Canadian Cancer Society, 2008).  Although most patients with stage IV high risk disease respond to front-line therapy, 50-60% will relapse and the prognosis for these children remains poor, with most dying from progressive disease. These children often suffer tumor related pain and undergo frequent cycles of chemotherapy for disease control, resulting in side effects such as febrile neutropenia, and many visits to hospital for supportive and follow up care.  The literature describes that 131I- MIBG therapy is effective in the treatment of refractory and relapse disease although is not a cure.  In a large multi-institutional phase 2 trial examining 131I-MIBG as monotherapy Matthay et al, concluded that this targeted radionuclide is highly active and effective in the treatment of refractory or relapse high risk neuroblastoma with an overall complete plus partial response rate of 36%.

Access for Canadian families has been limited by a lack of Canadian 131I- MIBG facilities. Currently there is only 1 center in Canada and approximately 10 in the US that offer this therapy, and as a result families seeking 131I-MIBG therapy travel long distances to receive this treatment. As a leader in research and innovation SickKids gained approval for the construction and implementation of a 131I-MIBG therapy suite on the inpatient haematology/oncology unit. This presentation provided an overview of the planning, development and implementation of the 131I-MIBG program at SickKids.

Speakers:
Denise Mills, RN(EC), MN, NP
Nurse Practitioner, Division of Haematology/Oncology
The Hospital for Sick Children, Toronto
Lawrence S. Bloomberg Cross Appointment at Faculty of Nursing
University of Toronto, Toronto

Sharleen Sawicki, RN, BScN, CPHON
Registered Nurse, Division of Haematology/Oncology
The Hospital for Sick Children, Toronto

Posted in 2013 Pre-Symposium Nursing Seminar - Innovation in Pediatric Oncology Nursing, Education for Health Professionals | Tagged 2013 Pre-Symposium Nursing Seminar, MIBG, neuroblastoma, relapse

The Heterogeneity of Acute Lymphoblastic Leukemia – Complexities of Risk Stratification in ALL

Posted on March 4, 2014 by admin

Presentation Description: In the last 20 years technologies have advanced the diagnosis of acute lymphoblastic leukemia (ALL). It has been learned that ALL is a diverse and heterogeneous disease with varying biological features. Today genetic alterations can be found in almost all cases of childhood ALL. These genetic alterations are random and include chromosomal numerical losses or gains, or whole or partial translocations. As the presence of genetic alterations informs both the prognosis and risk assignment of childhood ALL the current standard of care for diagnosis includes a bundle of tests including cytomorphology and cytochemistry with immunophenotyping, cytogenetic analysis and molecular assessment. This spotlight on ALL presentation reviewed both historical and newly discovered ALL biology and describe the increasing complex risk assignment of patients diagnosed with ALL. The presentation also highlighted early precursor T ALL, intrachromosomal amplification of chromosome 21, and an update of Philadelphia positive ALL (t(9:22)) with corresponding influences on current treatment and therapies in development.

Speaker:

Sue Zupanec, MN NP Pediatrics
Nurse Practitioner, Leukemia and Lymphoma Program
The Hospital for Sick Children, Toronto

Posted in 2013 Pre-Symposium Nursing Seminar - Innovation in Pediatric Oncology Nursing, Education for Health Professionals | Tagged 2013 Pre-Symposium Nursing Seminar, acute lymphoblastic leukemia (ALL), genetic alterations

Post navigation

← Older posts

Donate

Blog

Education Portal
Survivor Conference
All Categories

Categories

Newsletter Sign-Up

Please leave this field empty

@POGO4Kids

January 30, 2023

We’re excited to have @TD_Canada as a POGO PJ Party sponsor! Thank you for the support to help ensure everyone affected by #childhoodcancer has access to the best care and support. Learn more here: http://pogopjparty.com #POGOPJParty

Reply on Twitter 1620130019392774144 Retweet on Twitter 1620130019392774144 Like on Twitter 1620130019392774144 3 Twitter 1620130019392774144

Follow @POGO4Kids

Quick Links

  • For Professionals
    • Read Cancer Care Plan
    • Review our Guidelines
    • Request Research Data
  • Families & Kids
    • Get POGO AfterCare
    • Meet with a POGO Nurse
    • Get Care Closer to Home
  • For Survivors
    • Find Local Resources
    • Set Goals for your Future
    • Educate Yourself
  • Get Involved
    • Host an Event for POGO
    • Volunteer with POGO
    • Partner with POGO
  • About Us
    • Our Mission and Vision
    • Childhood Cancer Care Plan
    • POGO Land Acknowledgement
    • Diversity, Equity, Inclusion
    • Our Board
    • Our Partners
    • Our Donors
    • Privacy
    • Accessibility
    • Reports
    • Newsroom
    • Job Opportunities
    • Staff List
  • Programs & Support
    • Patient Care Programs
    • Financial Assistance
    • Survivor Care
    • Cancer Resources
    • Inspiring Stories
    • Clinical and Program Advisory Committees
  • Education
    • POGO Virtual Education
    • Indigenous Resource Guide
    • All Education Events & Conferences
  • Healthcare Practice
    • COVID-19 Updates
    • Pediatric Oncology Nursing
    • Clinical Practice Guidelines
    • POGO Satellite Manual
  • Research & Data
    • 2020 POGO Surveillance Report
    • POGO Research Unit
    • POGONIS – Childhood Cancer Database
    • Data Reports
    • Data Requests
  • Get Involved
    • Pajamas and Pancakes
    • Birthday Parties for POGO
    • Events
    • Volunteer
  • Ways to Give
    • Donate
    • Gifts of Stock and Securities
    • Become a Corporate Partner
    • Gifts in Honour/Memory
    • Legacy Gifts
    • Shop Online/Earn Cash Back

©2022 Pediatric Oncology Group of Ontario

480 University Avenue, Suite 1014 | Toronto, Ontario, M5G 1V2, Canada | Charitable Registration Number: 871067245RR0001 |
1-855-FOR POGO (367-7646) | Contact Us | Website Privacy Policy | Website Disclaimer | Satellite Manual Disclaimer |